1. Home
  2. RLAY vs ORRF Comparison

RLAY vs ORRF Comparison

Compare RLAY & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • ORRF
  • Stock Information
  • Founded
  • RLAY 2015
  • ORRF 1919
  • Country
  • RLAY United States
  • ORRF United States
  • Employees
  • RLAY N/A
  • ORRF N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • ORRF Major Banks
  • Sector
  • RLAY Health Care
  • ORRF Finance
  • Exchange
  • RLAY Nasdaq
  • ORRF Nasdaq
  • Market Cap
  • RLAY 803.4M
  • ORRF 674.4M
  • IPO Year
  • RLAY 2020
  • ORRF N/A
  • Fundamental
  • Price
  • RLAY $5.48
  • ORRF $33.73
  • Analyst Decision
  • RLAY Strong Buy
  • ORRF Buy
  • Analyst Count
  • RLAY 8
  • ORRF 2
  • Target Price
  • RLAY $17.25
  • ORRF $42.00
  • AVG Volume (30 Days)
  • RLAY 1.6M
  • ORRF 102.7K
  • Earning Date
  • RLAY 11-05-2025
  • ORRF 10-21-2025
  • Dividend Yield
  • RLAY N/A
  • ORRF 3.20%
  • EPS Growth
  • RLAY N/A
  • ORRF N/A
  • EPS
  • RLAY N/A
  • ORRF 2.24
  • Revenue
  • RLAY $8,355,000.00
  • ORRF $233,724,000.00
  • Revenue This Year
  • RLAY $27.33
  • ORRF $30.74
  • Revenue Next Year
  • RLAY $8.87
  • ORRF N/A
  • P/E Ratio
  • RLAY N/A
  • ORRF $15.06
  • Revenue Growth
  • RLAY N/A
  • ORRF 80.10
  • 52 Week Low
  • RLAY $1.78
  • ORRF $25.57
  • 52 Week High
  • RLAY $7.07
  • ORRF $41.99
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 75.63
  • ORRF 40.85
  • Support Level
  • RLAY $5.17
  • ORRF $33.14
  • Resistance Level
  • RLAY $5.42
  • ORRF $34.93
  • Average True Range (ATR)
  • RLAY 0.29
  • ORRF 0.82
  • MACD
  • RLAY 0.08
  • ORRF -0.22
  • Stochastic Oscillator
  • RLAY 95.97
  • ORRF 21.45

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.

Share on Social Networks: